CD70 is a novel therapeutic target for EGFR mutant NSCLC with acquired, EMT-associated EGFR TKI resistance

被引：0

作者：

Nilsson, Monique B. ^{[1
]}

Yang, Yan ^{[1
]}

Patel, Sonia ^{[1
]}

Heeke, Simon ^{[1
]}

Le, Xiuning ^{[1
]}

Aruguman, Thiru ^{[1
]}

Robichaux, Jacqulyne ^{[1
]}

Yu, Xiaoxing ^{[1
]}

Poteete, Alissa ^{[1
]}

Ren, Xiaoyang ^{[1
]}

Diao, Lixia ^{[1
]}

Shen, Li ^{[1
]}

Wang, Qi ^{[1
]}

Zhang, Fahao ^{[1
]}

Clemente, Leticia Campos ^{[1
]}

Soto, Luisa Solis ^{[1
]}

Shi, Chunhua ^{[1
]}

Tran, Hai ^{[1
]}

Bock, Jason ^{[1
]}

Wang, Jing ^{[1
]}

Wistuba, Ignacio I. ^{[1
]}

Minna, John D. ^{[2
]}

Heymach, John V. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[2] Univ Texas SouthWestern Med Ctr, Dallas, TX USA

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1827

引用

页数：1

共 50 条

[31] Response to pemetrexed rechallenge after acquired resistance of EGFR-TKI in a patient with advanced NSCLC
Li, Shuai
Zhou, Fangyu
Ren, Shengxiang
Zhou, Caicun
LUNG CANCER, 2014, 84 (02) : 203 - 205
[32] Wnt Signal Pathway and EMT Gene Expressions Are Possible Mechanisms of Acquired Resistance of EGFR-TKI
Xu, X.
Lee, J. C.
Chung, J-H
LABORATORY INVESTIGATION, 2010, 90 : 415A - 415A
[33] Wnt Signal Pathway and EMT Gene Expressions Are Possible Mechanisms of Acquired Resistance of EGFR-TKI
Xu, X.
Lee, J. C.
Chung, J-H
MODERN PATHOLOGY, 2010, 23 : 415A - 415A
[34] Cigarette smoke extract exposure induces EGFR-TKI resistance in EGFR-mutated NSCLC via mediating Src activation and EMT
Li, Dandan
Zhang, Lu
Zhou, Junhao
Chen, Hong
LUNG CANCER, 2016, 93 : 35 - 42
[35] Cigarette Smoke Extract Exposure Induces EGFR-Tki Resistance In EGFR-Mutated Nsclc Via Mediating Src Activation And Emt
Chen, H.
Li, D.
Zhang, L.
Zhou, J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[36] Honokiol, a natural product, overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib
Zang, Hongjing
Fan, Songqing
Arbiser, Jack
Owonikoko, Taofeek K.
Ramalingam, Suresh S.
Sun, Shi-Yong
CANCER RESEARCH, 2019, 79 (13)
[37] LOSS OF AMPLIFIED EGFR GENE WITH MUTATION AS A NOVEL MECHANISM OF ACQUIRED RESISTANCE TO EGFR-TKIS IN EGFR MUTATED NSCLC CELLS
Furugaki, K.
Iwai, T.
Moriya, Y.
Fujimoto-Ouchi, K.
ANNALS OF ONCOLOGY, 2012, 23 : 390 - 391
[38] Is CD73 Expression a Druggable Mechanism of Resistance in EGFR-TKI-Treated EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)?
Eide, I. J.
Dyrbekk, A. P.
Helland, A.
Ekman, S.
Koivunen, J.
Cicenas, S.
Gronberg, B.
Bisha, I.
Haberichter, T.
Lakis, S.
Chan, J.
Lewis, A.
Martin, P.
Cooper, Z.
Brustugun, O. T.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1154 - S1154
[39] Evolution of MET and NRAS gene amplification as acquired resistance mechanisms in EGFR mutant NSCLC
Peters, T. L.
Patil, T.
Le, A. T.
Davies, K. D.
Brzeskiewicz, P. M.
Nijmeh, H.
Bao, L.
Camidge, D. R.
Aisner, D. L.
Doebele, R. C.
NPJ PRECISION ONCOLOGY, 2021, 5 (01)
[40] Evolution of MET and NRAS gene amplification as acquired resistance mechanisms in EGFR mutant NSCLC
T. L. Peters
T. Patil
A. T. Le
K. D. Davies
P. M. Brzeskiewicz
H. Nijmeh
L. Bao
D. R. Camidge
D. L. Aisner
R. C. Doebele
npj Precision Oncology, 5

← 1 2 3 4 5 →